BeStock  

Xeris Pharmaceuticals XERS

US equityMarket cap rank #2842Drug Manufacturers - Specialty & Generic
$10.13 +$1.05 (+11.56%)
Pre-market · Oct 6, 5:10 am ET · After hours $10.11 -0.20%
Open$9.15
Prev close$9.08
Day range$9.12 – $10.24
Volume4.66M
Market cap$1.85B
P/E (TTM)–
Dividend yield–

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Recorlev$56.78M 61.7%
  • Gvoke$22.55M 24.5%
  • Keveyis$11.68M 12.7%
  • Royalty, contract and other revenue$1.10M 1.2%

Cash flow

Line item 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2
-Change In Other Working Capital $4.85M -$4.93M $2.09M -$269,000.00 -$188,000.00
-Change in Payables and Accrued Expense $4.82M $9.01M -$1.98M $16.76M $7.72M
-Change in Prepaid Assets -$4.49M $145,000.00 $1.25M -$5.15M $270,000.00
-Change in Inventory -$9.50M $851,000.00 -$4.01M -$4.09M -$7.57M
-Change in Receivables -$1.81M -$5.25M $2.70M -$703,000.00 -$6.72M
Change in Working Capital -$6.60M -$603,000.00 -$373,000.00 $6.14M -$6.88M
Other Non-Cash Items $907,000.00 $889,000.00 $866,000.00 $843,000.00 $820,000.00
Depreciation & Depletion & Amortization $3.21M $3.21M $3.20M $3.19M $3.16M
Net Income from Continuing Operations -$31.10M $2.23M $11.08M $621,000.00 -$1.93M
Net cash flow from continuing operations $8.26M $9.87M $20.04M $18.43M $182,000.00
Operating Cash Flow $8.26M $9.87M $20.04M $18.43M $182,000.00
-Change in Other Current Liabilities -$477,000.00 -$434,000.00 -$422,000.00 -$412,000.00 -$390,000.00
Net cash flow from investing -$209,000.00 -$325,000.00 -$333,000.00 -$71,000.00 -$279,000.00
Free Cash Flow $8.05M $9.55M $19.71M $18.36M -$97,000.00
Beginning Cash Balance $115.77M $115.06M $95.62M $63.41M $62.56M
Net Change in Cash $10.00M $708,000.00 $19.44M $32.21M $845,000.00
Ending Cash Balance $125.77M $115.77M $115.06M $95.62M $63.41M
Proceeds from Stock Option Exercised $1.53M $847,000.00 -$7.89M $14.33M $1.80M
Net Common Stock Issuance $409,000.00 -$9.68M $7.63M -$478,000.00 -$860,000.00
Net Cash Flow from Continuing Financing Activities $1.94M -$8.84M -$266,000.00 $13.85M $942,000.00
Financing Cash Flow $1.94M -$8.84M -$266,000.00 $13.85M $942,000.00
Capital Expenditure -$209,000.00 -$325,000.00 -$333,000.00 -$71,000.00 -$279,000.00
Net Cash Flow from Continuing Investing Activities -$209,000.00 -$325,000.00 -$333,000.00 -$71,000.00 -$279,000.00
Net Investment Purchase and Sale – – $0.00 – –
Net Issuance Payments Of Debt – – $0.00 – –
Deferred Tax – – $0.00 – –

Discussion

No comments yet — be the first to weigh in on XERS.

Leave a comment

Scroll to Top